期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HER2基因与乳腺癌关系的研究进展

在线阅读 下载PDF
导出
摘要 近年来,肿瘤生物标志物(TM)广泛地被用于恶性肿瘤的诊断、预后、治疗及对疗效的判断等方面。在乳腺癌相关的TM中,目前研究得最多的是HER2,它与乳腺癌的转移预后都有密切关系,同时在乳腺癌的分子靶向治疗和术后新辅助治疗方面也有很大的应用前景。
作者 廖天 陆云飞
机构地区 广西医科大学第一附属医院胃肠腺体外科
出处 《中国实用医药》 2007年第9期89-91,共3页 China Practical Medicine
关键词 人表皮生长因子受体-2 乳腺癌
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1[1]Slamon DJ,Clark GM,Wong SG,et al.Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene[J].Science,1987,235 (4785):177-182.
  • 2[2]Lohrish C,Piccart M.An overview of HER-2[J].Semin Oncol,2001,28:3-11.
  • 3[3]Wingens M,Walma T,Van Ingen H,et al.Structural analysis of an epidermal growth factor/transforming growth factoralpha chimera with unique ErbB binding specificity[J].J Biol Chem,2003,278 (40):39114-39123.
  • 4[4]SHIN H S,LEE H J,NISHIDA M,et al.Betacellulin and amphiregulin induce upregulation of cyclin Dl and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells[J].Circ Res,2003,93(4):302-310.
  • 5刘彩云,寿成超.乳腺癌患者血清HER-2/neu胞外域的临床意义[J].国际检验医学杂志,2006,27(3):237-239. 被引量：7
  • 6[6]Cell Markers And Cytogenetics Committees College Of American Pathologists.Clinical laboratory assays for HER-2/neu amplification and overexpression:quality assurance,standardization,and proficiency testing[J].Arch Pathol Lab Med,2002,126(7):803-808.
  • 7[7]Ellis IO,Dowsett M,Bartlett J,et al.Recommendations for HER2 testing in theUK[J].J Clin Pathol,2000,53(12):890-892.
  • 8[8]Mclntyre R,Bigler L,Dellinger T,et al.Oral contraceptive usage and the expression of CA15-3 and c-erbB-2 in the saliva of healthy women[J].Oral Surg Oral Med,1999,88(6):687-90.
  • 9[9]Streckfus C,Bigler L,Dellinger T,et al.The presence of soluble cerbB-2 in saliva and serum among women with breast carcinoma:a preliminsry study[J].Clin C ancer Res,2000,6(6):2363-70.
  • 10[10]Shin AA.Biologic and clinical significance of HER-2/neu(c-erbB-2)in breast cancer[J].Adv Anta Patrol,2000,7(3):158-166.

二级参考文献17

  • 1Carney WP,Neumann R,Lipton A,et al.Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer.Clin Chem,2003,49(10):1579-1598.
  • 2Carney WP,Neumann R,Lipton A,et al.Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.Clin Breast Cancer,2004,5(2):105-116.
  • 3Muller V,Witzel I,Luck HJ,et al.Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.Breast Cancer Res Treat,2004,86(1):9-18.
  • 4Luftner D,Henschke P,Kafka A,et al.Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization,automation and timing.Int J Biol Markers,2004,19(1):1-13.
  • 5Muller V,Thomssen C,Karakas C,et al.Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.Int J Biol Markers,2003,18(1):13-20.
  • 6Esteva FJ,Valero V,Booser D,et al.Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.J Clin Oncol,2002,20(7):1800-1808.
  • 7Saghatchian M,Guepratte S,Hacene K,et al.Serum HER-2 extracellular domain:relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patients.Int J Biol Markers,2004,19(1):14-22.
  • 8Pichon MF,Hacene K,Guepratte S,et al.Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients.Clin Lab,2004,50(3-4):163-170.
  • 9Schippinger W,Regitnig P,Bauernhofer T,et al.The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.Oncol Rep,2004,11(6):1331-1336.
  • 10Kostler WJ,Schwab B,Singer CF,et al.Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.Clin Cancer Res,2004,10(5):1618-1624.

共引文献6

中国实用医药
2007年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部